These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2061618)

  • 1. Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50).
    Servais G; Walmagh J; Duchateau J
    J Immunol Methods; 1991 Jun; 140(1):93-100. PubMed ID: 2061618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitation of alternative pathway complement function by timed lysis assay.
    Jones BM
    J Immunol Methods; 1979; 29(3):287-92. PubMed ID: 114593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.
    Jessen TE; Barkholt V; Welinder KG
    J Immunol Methods; 1983 May; 60(1-2):89-100. PubMed ID: 6406606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes.
    Van Dijk H; Rademaker PM; Willers JM
    J Immunol Methods; 1980; 36(1):29-39. PubMed ID: 7204994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of Regulatory Activity for the Complement Alternative PathwayUsing an Adaptation of the AP
    Falcon SC; Gordon DL; Carr JM
    Bio Protoc; 2018 Dec; 8(24):e3116. PubMed ID: 34532558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computerized microassay for complement hemolytic activity using an automated spectrophotometer.
    Narchi G; Milani S; Tedesco F
    Ric Clin Lab; 1987; 17(1):27-33. PubMed ID: 3589400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between the haemolytic activities of the human complement system and complement components.
    Takada A; Imamura Y; Takada Y
    Clin Exp Immunol; 1979 Feb; 35(2):324-8. PubMed ID: 436337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preanalytical classical and alternative complement pathway activity loss.
    Vercauteren KOA; Lambrecht S; Delanghe J
    Biochem Med (Zagreb); 2019 Oct; 29(3):030701. PubMed ID: 31379459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microplate assay to measure classical and alternative complement activity.
    Puissant-Lubrano B; Fortenfant F; Winterton P; Blancher A
    Clin Chem Lab Med; 2017 May; 55(6):845-853. PubMed ID: 28125402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human factor B activity of the properdin system by human and guinea-pig sera.
    Lambré C
    Ann Immunol (Paris); 1979; 130C(1):71-8. PubMed ID: 373582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive microassay for the murine alternative complement pathway.
    Joiner KA; Shahon R; Gelfand JA
    J Immunol Methods; 1979; 31(3-4):283-90. PubMed ID: 521632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified assays of hemolytic activity of the classical and alternative complement pathways.
    Nilsson UR; Nilsson B
    J Immunol Methods; 1984 Aug; 72(1):49-59. PubMed ID: 6747305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alternative complement pathway-mediated lysis of rabbit erythrocytes is enhanced by natural anti-Galalpha1-3Gal antibodies.
    Tomlinson S; Nussenzweig V
    J Immunol; 1997 Dec; 159(11):5606-9. PubMed ID: 9548503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative pathway of complement by antiserum to factor B.
    Wilson MR; Arroyave CM; Tan EM
    J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a hemolytic assay of the alternative complement pathway in human serum.
    Coonrod JD; Jenkins SD
    Am J Clin Pathol; 1980 Aug; 74(2):167-73. PubMed ID: 7405895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the optimal reaction conditions for assay of the mouse alternative complement pathway.
    Van Dijk H; Rademaker PM; Klerx JP; Willers JM
    J Immunol Methods; 1985 Dec; 85(2):233-43. PubMed ID: 4078314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of optimal reaction conditions for an assay of the human alternative complement pathway.
    Joiner KA; Hawiger A; Gelfand JA
    Am J Clin Pathol; 1983 Jan; 79(1):65-72. PubMed ID: 6849295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional characterization of complement C4 and C1s-like molecules in teleost fish: insights into the evolution of classical and alternative pathways.
    Boshra H; Gelman AE; Sunyer JO
    J Immunol; 2004 Jul; 173(1):349-59. PubMed ID: 15210793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.